ET Intelligence Group: Ahmedabad-based Concord Biotech is a global supplier of bio-pharmaceutical APIs and formulations, serving more than 70 countries, including regulated markets like the United States, Europe and Japan.
Polycab shares slip 7% after Q2 results. What should investors do?
Polycab India’s shares fell nearly 7% despite a 3.5% YoY net profit increase, driven by strong revenue growth but rising expenses. Analysts remain positive, with